We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Recce Pharmaceuticals is a biotechnology business based in Australia. Recce Pharmaceuticals shares (RCE) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. Recce Pharmaceuticals has a trailing 12-month revenue of around $997,333. If you're looking to buy shares, check out the steps below.
How to buy shares in Recce Pharmaceuticals
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the ASX. Our table can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, such as your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Recce Pharmaceuticals . Find the share by name or ticker symbol: RCE. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Recce Pharmaceuticals reaches your desired price. Look into dollar-cost averaging to spread out your risk, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check on your investment. Congratulations, you own a part of Recce Pharmaceuticals . Optimise your portfolio by tracking how your stock and the business performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that affect your stock.
Our top pick for
US stocks

Our top pick for
Best Overall Broker

Our top pick for
Best low-cost broker

What's in this guide?
- Recce Pharmaceuticals key stats
- Compare share trading platforms
- Is Recce Pharmaceuticals stock a buy or sell?
- Recce Pharmaceuticals performance over time
- Recce Pharmaceuticals 's financials
- How volatile are Recce Pharmaceuticals shares?
- Does Recce Pharmaceuticals pay a dividend?
- Other common questions
Recce Pharmaceuticals stock price (ASX:RCE)
Use our graph to track the performance of RCE stocks over time.Recce Pharmaceuticals shares at a glance
52-week range | $0.74 - $1.38 |
---|---|
50-day moving average | $0.8982 |
200-day moving average | $0.9611 |
Target price | N/A |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-0.053 |
Compare share trading platforms
Is it a good time to buy Recce Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Recce Pharmaceuticals price performance over time
Historical closes compared with the last close of A$0.8
1 week (2022-05-12) | 3.90% |
---|---|
1 month (2022-04-22) | -10.61% |
3 months (2022-02-22) | -20.00% |
6 months (2021-11-22) | -10.61% |
1 year (2021-05-21) | -23.44% |
---|---|
2 years (2020-05-22) | 37.93% |
3 years (2019-05-22) | 272.09% |
5 years (2017-05-22) | 290.24% |
Recce Pharmaceuticals financials
Revenue TTM | $997,333 |
---|---|
Gross profit TTM | $-4,067,212 |
Return on assets TTM | -24.88% |
Return on equity TTM | -42.75% |
Profit margin | 0% |
Book value | 0.117 |
Market capitalisation | $141.4 million |
TTM: trailing 12 months
Recce Pharmaceuticals share dividends
We're not expecting Recce Pharmaceuticals to pay a dividend over the next 12 months.
Recce Pharmaceuticals share price volatility
Over the last 12 months, Recce Pharmaceuticals 's shares have ranged in value from as little as $0.74 up to $1.38. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while Recce Pharmaceuticals 's is 1.3431. This would suggest that Recce Pharmaceuticals 's shares are more volatile than the average for this exchange and represent, relatively speaking, a higher risk (but potentially also market-beating returns).
Recce Pharmaceuticals overview
Recce Pharmaceuticals Ltd, a biotechnology company, engages in the research, development, and commercialization of synthetic anti?infectives in Australia, the United States, and the United Kingdom. The company's lead candidate is RECCE 327 to treat blood infections and sepsis derived from E. coli and S. aureus bacteria, including their superbug forms. It also develops RECCE 529, a synthetic anti-infective for viral infections; and RECCE 435, a synthetic polymer anti-infective. The company was formerly known as Recce Limited and changed its name to Recce Pharmaceuticals Ltd in November 2017. Recce Pharmaceuticals Ltd was incorporated in 2007 and is headquartered in Sydney, Australia.
Recce Pharmaceuticals in the news
Frequently asked questions
More guides on Finder
-
How to invest in the OD6 Metals IPO
Everything we know about the OD6 Metals IPO, plus information on how to buy in.
-
How to buy Winton Land (WTN) shares
Steps to owning and managing Winton Land shares.
-
How to invest in the Summit Minerals IPO
Everything we know about the Summit Minerals IPO, plus information on how to buy in.
-
How to invest in Cosmos Global Digital Miners Access ETF (DIGA)
The picks and shovels approach is one way to gain exposure to the crypto market. Here is an ETF you could consider.
-
How to invest in the Regener8 Resources IPO
Everything we know about the Regener8 Resources IPO, plus information on how to buy in.
-
How to invest in the Cosmos Bitcoin ETF (CBTC)
While crypto ETFs remain a relatively new concept, here is how you can invest in one of the first physically back Bitcoin ETFs.
-
How to invest in 21Shares Ethereum ETF (EETH)
Here is your how to guide on buying the first Ethereum backed ETF in Australia.
-
How to invest in the Southern Palladium Limited IPO
Everything we know about the Southern Palladium Limited IPO, plus information on how to buy in.
-
How to invest in the Coolabah Metals IPO
Everything we know about the Coolabah Metals IPO, plus information on how to buy in.
Ask an Expert